Medical Crossfire

Real Experts. Real Opinions. Real Outcomes.

[PER @gotoPER]

The last discussion at #WinterLung is a @MedicalXFire on the standard of care for patients with metastatic NSCLC and PD-L1 >50%—I/O alone vs chemoimmunotherapy

[PER @gotoPER]

It’s Fabrice André @FAndreMD vs Dr. Nicholas Turner in a @MedicalXFire on early HER2-positive breast cancer at #ParisBreast18

[Phil Talamo @philtalamo]

Another fantastic @MedicalXFire at #Chemo18 - How Do You Use Liquid Biopsies in NSCLC? Featuring @benlevylungdoc @Jbauml Sarah Goldberg and Zofia Piotrowska... and we unveiled a new set for our green screen! @gotoPER

[PER @gotoPER]

Before & After @MedicalXFire filming at #Chemo18! Drs. @BenLevyLungDoc, @JBauml, Sarah Goldberg, and Zofia Piotrowska discuss how they use liquid biopsies in lung cancer

[Phil Talamo @philtalamo]

Right before lunch at #Chemo18 - @CathyEngMD moderating a @MedicalXFire on The MSI Story in GI and Lessons Learned Pan-Tumor

[Joshua Bauml, MD @Jbauml]

Lots of brainpower on the stage here to discuss biomarkers of response to IO, including @benlevylungdoc Dr Sarah Goldberg, Dr Mark Socinski, @HosseinBorghaei @DrRoyHerbstYale. #Chemo18 @gotoPER

[Medical Crossfire @MedicalXFire]

PD-L1 vs TMB vs Nothing At All? This Medical Crossfire on biomarkers in lung cancer starts now at #Chemo18

[Stephen V Liu, MD @StephenVLiu]

Lines are drawn! First line NSCLC options @MedicalXFire @gotoPER with @benlevylungdoc @HosseinBorghaei @DrRoyHerbstYale Mark Socinski and Sarah Goldberg #CFS2018

[PER @gotoPER]

Happening downstairs at #Chemo18, another @MedicalXFire live filming 🎥 this time on TNBC! Seats are filling up fast

[PER @gotoPER]

The last panel of Day 1 at #Chemo18: A @MedicalXFire on the roles of targeted therapies, I/O, and chemotherapy in advanced bladder cancer

[PER @gotoPER]

We’re recording 🎥 a @MedicalXFire on biosimilars in breast cancer at #Chemo18

[PER @gotoPER]

We’re here at ASTRO with a @MedicalXFire discussing how to overcome clinical inertia in glioblastoma multiforme. Join us for rad oncs, dinner, and CME!

[Malnati Brain Tumor Institute at Northwestern @BrainTumorInst]

Tonight at #ASTRO18, our co-director Roger Stupp, MD, will co-lead a @MedicalXFire satellite discussion on overcoming clinical inertia in #GBM. The speakers will weigh in on recent data sets and ways to move the field forward.

More details:
https://t.co/9KEhoDLNt0

[Benjamin Levy @benlevylungdoc]

We look chummy now but you should have seen the sparks fly on the medical crossfire - biomarkers for IO. Thanks for keeping me on my toes @Stephen Liu @HosseinBorghaei @CharuAggarwalMD @MedicalXFire

[Medical Crossfire @MedicalXFire]

It’s a Medical Crossfire at #gotoECIC! Immunotherapy or BRAF-targeted therapy for adjuvant melanoma? The experts weigh in.

[PER @gotoPER]

The debate is on! What is the preferred frontline therapy for targetable oncogenes in NSCLC? Drs. Heather Wakelee, Hak Choy, Sarah Goldberg, @T_Mitsudomi, Tony Mok, Ignatius Ou @oncoOuLungCA, and @KarenReckampMD take the stage for the last @MedicalXFire of the day at #gotoILC

[Medical Crossfire @MedicalXFire]

Up next, Medical Crossfire no. 2! Let’s address the current controversies facing immunotherapy in #LungCancer #gotoILC

[Medical Crossfire @MedicalXFire]

The first Medical Crossfire of the day is about to start! Its Dr. Fred Hirsch versus Dr. David Carbone on the future of biomarkers in I/O. Will PD-L1 expression or TMB prevail? #gotoILC

[Medical Crossfire @MedicalXFire]

There’s 3 Medical Crossfires happening at @gotoPER’s #gotoILC today! Don’t miss the debates on the future of biomarkers in #LungCancer, current controversies in the use of immunotherapy, and the battle between first- and third-generation agents for targeted therapy in NSCLC!

[Medical Crossfire @MedicalXFire]

Great exchange on differences in treating Hodgkin in the USA and Europe! https://t.co/w7g39imxvW

[Anas Younes, M.D. @DrAnasYounes]

You mean allo BMT. On the other hand auto SCT remains the standard of care for relapsed/refractory HL. Another difference with European colleagues, I would not recommend allo before trying and failing auto SCT for r/r HL https://t.co/HxXzpWG6po